Literature DB >> 9006343

In situ stromal expression of the urokinase/plasmin system correlates with epithelial dysplasia in colorectal adenomas.

I Sordat1, P Chaubert, P Protiva, L Guillou, L Mazzucchelli, E Saraga, J Benhattar, C Trân-Thang, A L Blum, G Dorta, B Sordat.   

Abstract

An increase of urokinase-type plasminogen activator (uPA) and a decrease of tissue-type PA (tPA) have been associated with the transition from normal to adenomatous colorectal mucosa. Serial sections from 25 adenomas were used to identify PA-related caseinolytic activities by in situ zymography, blocking selectively uPA or tPA. The distribution of uPA, tPA, and type 1 PA inhibitor mRNAs was investigated by nonradioactive in situ hybridization, and the receptor for uPA was detected by immunostaining. Low- and high-grade epithelial cell dysplasia was mapped histologically. Results show that 23 of 25 adenomas expressed uPA-related lytic activity located predominantly in the periphery whereas tPA-related activity was mainly in central areas of adenomas. In 15 of 25 adenomas, uPA mRNA was expressed in stromal cells clustered in foci that coincided with areas of uPA lytic activity. The probability of finding uPA mRNA-reactive cells was significantly higher in areas with high-grade epithelial dysplasia. uPA receptor was mainly stromal and expressed at the periphery. Type 1 PA inhibitor mRNA cellular expression was diffuse in the stroma, in endothelial cells, and in a subpopulation of alpha-smooth muscle cell actin-reactive cells. These results show that a stromal up-regulation of the uPA/plasmin system is associated with foci of severe dysplasia in a subset of colorectal adenomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006343      PMCID: PMC1858534     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Plasminogen activators in human colorectal neoplasia.

Authors:  J S Gelister; M Mahmoud; M R Lewin; P J Gaffney; P B Boulos
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

Review 2.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

3.  In vivo measurements in familial polyposis: kinetics and location of proliferating cells in colonic adenomas.

Authors:  C Lightdale; M Lipkin; E Deschner
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

4.  Plasminogen activators in experimental colorectal neoplasia: a role in the adenoma-carcinoma sequence?

Authors:  J S Gelister; M R Lewin; H E Driver; F Savage; M Mahmoud; P J Gaffney; P B Boulos
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

5.  The evolution of cancer of the colon and rectum.

Authors:  T Muto; H J Bussey; B C Morson
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

6.  Study of the cell proliferation kinetics in ulcerative colitis, adenomatous polyps, and cancer.

Authors:  T Kanemitsu; A Koike; S Yamamoto
Journal:  Cancer       Date:  1985-09-01       Impact factor: 6.860

7.  Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas.

Authors:  J D Tissot; J Hauert; F Bachmann
Journal:  Int J Cancer       Date:  1984-09-15       Impact factor: 7.396

8.  Expression of urokinase receptor in various stromal-cell populations in human colon cancer: immunoelectron microscopical analysis.

Authors:  H Ohtani; C Pyke; K Danø; H Nagura
Journal:  Int J Cancer       Date:  1995-09-15       Impact factor: 7.396

9.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

Authors:  R H Riddell; H Goldman; D F Ransohoff; H D Appelman; C M Fenoglio; R C Haggitt; C Ahren; P Correa; S R Hamilton; B C Morson
Journal:  Hum Pathol       Date:  1983-11       Impact factor: 3.466

10.  A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.

Authors:  O Skalli; P Ropraz; A Trzeciak; G Benzonana; D Gillessen; G Gabbiani
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  5 in total

1.  The plasminogen system in microdissected colonic mucosa distant from an isolated adenoma.

Authors:  Francois Saucy; Daniel Bachmann; Olivier Peterman; Bernard Sordat; Isabelle Sordat; Gian Dorta
Journal:  Pathol Oncol Res       Date:  2010-05-23       Impact factor: 3.201

2.  Urokinase type plasminogen activator receptor expression in colorectal neoplasms.

Authors:  S Suzuki; Y Hayashi; Y Wang; T Nakamura; Y Morita; K Kawasaki; K Ohta; N Aoyama; S R Kim; H Itoh; Y Kuroda; W F Doe
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

3.  Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas.

Authors:  P Protiva; I Sordat; P Chaubert; E Saraga; C Trân-Thang; B Sordat; A L Blum; G Dorta
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

4.  Expression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: role of oxygenation status and tumour size.

Authors:  M Weinmann; O Thews; T Schroeder; P Vaupel
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

Review 5.  Fibroblast Subsets in Intestinal Homeostasis, Carcinogenesis, Tumor Progression, and Metastasis.

Authors:  Hao Dang; Tom J Harryvan; Lukas J A C Hawinkels
Journal:  Cancers (Basel)       Date:  2021-01-07       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.